Insmed (INSM) Cash from Investing Activities (2010 - 2026)

Insmed's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $265.5 million for Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 230.2% year-over-year to $265.5 million in Q1 2026; TTM through Mar 2026 was $120.5 million, a 115.1% increase from a year earlier, with the FY2025 full-year figure at -$64.6 million, up 88.93% from the prior year.
• Cash from Investing Activities slipped to $265.5 million in Q1 2026 per INSM's latest filing, from $389.4 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $389.4 million in Q4 2025 and bottomed at -$1.0 billion in Q3 2024.
• The 5-year median for Cash from Investing Activities is $20.3 million (2022), against an average of -$37.7 million.
• Biggest YoY gain for Cash from Investing Activities was 7207.71% in 2024; the steepest drop was 14140.45% in 2024.
• Year by year, Cash from Investing Activities stood at $20.3 million in 2022, then tumbled by 91.12% to $1.8 million in 2023, then jumped by 7207.71% to $131.8 million in 2024, then jumped by 195.55% to $389.4 million in 2025, then slumped by 31.81% to $265.5 million in 2026.
• Per Business Quant, the three latest INSM Cash from Investing Activities figures stand at $265.5 million (Q1 2026), $389.4 million (Q4 2025), and -$762.2 million (Q3 2025).